Biotech company, Ingenza, has relocated to Roslin Innovation Centre, a £30 million, multi-purpose research hub on the University of Edinburgh’s Easter Bush Campus. The centre offers 41,000 sq ft of flexible laboratory and office space, and Ingenza will occupy 11,000 sq ft on the top floor, with its own secure access to ensure security and confidentiality. The move – scheduled to take place in July...
Transfusion diagnostics company, Quotient, has official opened its state-of-the-art Allan-Robb Campus within the Scottish Enterprise Biocampus just outside of Edinburgh. Paul Cowan, Founder of Quotient, said, “The inauguration of the Allan-Robb Campus testifies to Quotient’s long-term commitment to the global transfusion diagnostics market, both through the on-going supply of liquid reagents and through its transformational MosaiQ™ transfusion diagnostics system that provides a comprehensive automated testing solution,...
In a bid to save £200,000 a year, Scottish life sciences firm Collagen Solutions is planning to move some of its manufacturing from New Zealand to Glasgow. The Glasgow-based firm, which specialises in medical grade collagen and tissue components, said it is looking at a restructuring of its business in New Zealand to focus on tissue collection and processing. Chief executive Jamal Rushdy, said: “ There are two...
Scotland’s bio-revolution is attracting unprecedented international interest – and nowhere is it more firmly on the radar than in the meetings, incentives, conventions and exhibitions (MICE) sector. Rory Archibald, business development manager at VisitScotland, says: “Scotland has one of the largest clusters of scientists working in life sciences – bigger than anywhere in Europe – so it is a massive draw. “There have been several...
Following the Scotsman Life Sciences Conference on 21st November, Life Sciences Scotland have developed a new mini series to address key issues and business concerns raised through discussions at the event. The aim is to sign-post where to find information relevant to the industry. The first mini-series shared through social media began on the 11th December with a focus on Funding & Support available to...
SGS, a leading bio/pharmaceutical, analytical and bio-analytical contract solutions provider, today announced that it is introducing a Sanger sequencing service at its Glasgow, UK, laboratory, to support genetic stability testing and perform identity testing on cell banks, plasmids, and viral seeds/vectors. The new service, which will be available under Good Manufacturing Practice (GMP) conditions, is supported by an investment in ABI Life Technologies’ validated 3500xl...